Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema

doi:10.4239/wjd.v12.i8.1220

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6365)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

458

WORD

109

HTML

3106

Figures (1-3)

395

Tables (1-1)

237

Sum=4305

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

291

Download

652

Sum=943

Publishing Process of This Article

Item

Count

Browse

342

Download

775

Sum=1117

Aug 15, 2021 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Aug 15, 2021; 12(8): 1220-1232
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1220

Full Size Figure Download Figure

Figure 2 Ozurdex single-use intravitreal injection device with a 23-gauge needle.

Citation: Karti O, Saatci AO. Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema. World J Diabetes 2021; 12(8): 1220-1232
URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1220.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1220